Neoadjuvant chemotherapy for Ewing's tumour of bone: recent experience at the Rizzoli Orthopaedic Institute
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 38 (17), 2243-2251
- https://doi.org/10.1016/s0959-8049(02)00148-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Localized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86Journal of Clinical Oncology, 2001
- Prognostic Factors in Nonmetastatic Ewing’s Sarcoma of Bone Treated With Adjuvant Chemotherapy: Analysis of 359 Patients at the Istituto Ortopedico RizzoliJournal of Clinical Oncology, 2000
- Non Conventional Fractionation in Radiotherapy of the Musculo-Skeletal SarcomasTumori Journal, 1998
- Long-term results from the first UKCCSG Ewing's tumour study (ET-1)European Journal Of Cancer, 1997
- Ewing's sarcoma of the femur: Prognosis in 69 patients treated by the CESS groupActa Orthopaedica, 1997
- Treatment of femoral Ewing's sarcomaCancer, 1996
- Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities.Journal of Clinical Oncology, 1993
- Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.Journal of Clinical Oncology, 1990
- Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescentsZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- Curability of ewing's sarcoma and considerations for future therapeutic trialsCancer, 1978